Inhibrx Biosciences (INBX) Earnings Date & Reports

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

INBX is expected to report earnings to fall 16.28% to -179 cents per share on August 19

Inhibrx Biosciences INBX Stock Earnings Reports

Q2'26

Est.

$-1.80

Q1'26

Beat

by $0.08

Q4'25

Missed

by $0.48

Q3'25

Missed

by $0.71

Q2'25

Missed

by $0.30

The last earnings report on May 14 showed earnings per share of -215 cents, beating the estimate of -223 cents. With 235.31K shares outstanding, the current market capitalization sits at 1.37B.

View a ticker or compare two or three

Compare

INBX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for INBX